Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza H3N2 Vaccine in Rheumatologic Diseases
NCT03540823Phase 4Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Apr 2018
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Phase 4, open-label trial in influenza, sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Apr 2018; status: completed.
02
Conditions
influenza
Beyond the preview
Go deeper on NCT03540823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03540823.